|
|
Article: Algene Biotechnologies Corporation Announces Results On Late-Onset Alzheimer Disease
- Article from:
- PR Newswire
- Article date:
- October 15, 1996
CopyrightCOPYRIGHT 1996 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
MONTREAL, Oct. 15 /PRNewswire/ - Algene Biotechnologies Corporation (Montreal Stock Exchange: AGN.B) announces that it has completed additional series of experiments pertaining to gene discovery in late-onset Alzheimer disease. Algene reports that it has identified 5 loci of interest (i.e. chromosomal regions that could harbor causal genes) for further gene prospection on Alzheimer disease.
"Although these results could still be considered as preliminary" said Dr. Denis Gauvreau, President and CEO of Algene, "we are very enthusiastic about the data as statistical power for these loci is reasonably high, and in any case higher than that established in control ...